Michael R. Hayden - 23 Dec 2024 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Michael R. Hayden
Issuer symbol
IONS
Transactions as of
23 Dec 2024
Net transactions value
+$181,079
Form type
4
Filing time
26 Dec 2024, 16:57:52 UTC
Previous filing
03 Jul 2024
Next filing
05 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Purchase $90,496 +2,500 +8.3% $36.20 32,719 23 Dec 2024 Direct
transaction IONS Common Stock Purchase $90,583 +2,500 +7.6% $36.23 35,219 23 Dec 2024 Direct
holding IONS Common Stock 2,000 23 Dec 2024 by Spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2.